Víctor Hontañón

993 total citations
28 papers, 297 citations indexed

About

Víctor Hontañón is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Víctor Hontañón has authored 28 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 18 papers in Hepatology and 7 papers in Infectious Diseases. Recurrent topics in Víctor Hontañón's work include Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (13 papers) and Liver Disease and Transplantation (12 papers). Víctor Hontañón is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Hepatitis C virus research (13 papers) and Liver Disease and Transplantation (12 papers). Víctor Hontañón collaborates with scholars based in Spain, United States and Italy. Víctor Hontañón's co-authors include Juan Berenguer, Juan González‐García, María Ángeles Jiménez‐Sousa, Leire Pérez‐Latorre, Salvador Resino, José Sanz, Cristina Díez, Luis Ibáñez, María Jesús Téllez and Ignacio de los Santos and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Víctor Hontañón

28 papers receiving 295 citations

Peers

Countries citing papers authored by Víctor Hontañón

Since Specialization

Citations

This map shows the geographic impact of Víctor Hontañón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Víctor Hontañón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Víctor Hontañón more than expected).

Fields of papers citing papers by Víctor Hontañón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Víctor Hontañón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Víctor Hontañón. The network helps show where Víctor Hontañón may publish in the future.

Co-authorship network of co-authors of Víctor Hontañón

This figure shows the co-authorship network connecting the top 25 collaborators of Víctor Hontañón. A scholar is included among the top collaborators of Víctor Hontañón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Víctor Hontañón. Víctor Hontañón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Altered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis 2024 ·Journal of Infection and Public Health ·Oscar Brochado‐Kith, Marta Rava, Juan Berenguer, Juan González‐García, David Rojo, Cristina Díez, Víctor Hontañón, Ana Virseda‐Berdices, Luis Ibáñez, (unknown), Antonio Olveira, Leire Pérez‐Latorre, Coral Barbas, Amanda Fernández‐Rodríguez, Salvador Resino, María Ángeles Jiménez‐Sousa	2
2	Clinical outcomes and prognostic factors after HCV clearance with DAA in HIV/HCV-coinfected patients with advanced fibrosis/cirrhosis 2024 ·Hepatology ·Juan Berenguer, Teresa Aldámiz‐Echevarría, Víctor Hontañón, Chiara Fanciulli, Carmen Quereda, Carmen Busca, Lourdes Domínguez, (unknown), Jorge Vergas, G. Gaspar, Lucio García‐Fraile, Cristina Díez, Marta de Miguel, José M. Bellón, Rafael Bañares, Juan González‐García	3
3	Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study 2024 ·Pharmaceuticals ·Daniel Sepúlveda‐Crespo, (unknown), (unknown), Belén Yélamos, Cristina Díez, Julián Gómez‐Gutiérrez, Víctor Hontañón, Juan Berenguer, Juan González‐García, Rubén Martín‐Escolano, Salvador Resino, Isidoro Martínez	1
4	Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study 2024 ·Frontiers in Pharmacology ·Rubén Martín‐Escolano, Ana Virseda‐Berdices, Juan Berenguer, Juan González‐García, Oscar Brochado‐Kith, (unknown), Cristina Díez, Víctor Hontañón, (unknown), Salvador Resino, María Ángeles Jiménez‐Sousa	1
5	Immune checkpoint proteins are associated with persistently high liver stiffness after successful HCV treatment in people with HIV: a retrospective study 2024 ·Frontiers in Immunology ·Rubén Martín‐Escolano, (unknown), Juan Berenguer, Juan González‐García, Oscar Brochado‐Kith, (unknown), Cristina Díez, Víctor Hontañón, Salvador Resino, María Ángeles Jiménez‐Sousa	1
6	Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients 2023 ·Biomedicine & Pharmacotherapy ·Rubén Martín‐Escolano, Ana Virseda‐Berdices, Juan Berenguer, Juan González‐García, Oscar Brochado‐Kith, Amanda Fernández‐Rodríguez, Cristina Díez, Víctor Hontañón, Salvador Resino, María Ángeles Jiménez‐Sousa	3
7	PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study 2023 ·Biomedicine & Pharmacotherapy ·(unknown), Oscar Brochado‐Kith, (unknown), Juan Berenguer, Juan González‐García, Isidoro Martínez, Cristina Díez, Víctor Hontañón, Leire Pérez‐Latorre, Amanda Fernández‐Rodríguez, María Ángeles Jiménez‐Sousa, Salvador Resino	1
8	Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients 2022 ·Biomedicine & Pharmacotherapy ·Ana Virseda‐Berdices, David Rojo, Isidoro Martínez, Juan Berenguer, Juan González‐García, Oscar Brochado‐Kith, Amanda Fernández‐Rodríguez, Cristina Díez, Víctor Hontañón, Leire Pérez‐Latorre, Rafael Micán, Coral Barbas, Salvador Resino, María Ángeles Jiménez‐Sousa	10
9	Negative impact of HIV infection on broad-spectrum anti-HCV neutralizing antibody titers in HCV-infected patients with advanced HCV-related cirrhosis 2022 ·Biomedicine & Pharmacotherapy ·Daniel Sepúlveda‐Crespo, Belén Yélamos, Cristina Díez, (unknown), Víctor Hontañón, (unknown), Juan Berenguer, Juan González‐García, Luis Ibáñez, (unknown), Antonio Olveira, Javier Martínez, Salvador Resino, Isidoro Martínez	2
10	Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study 2021 ·Frontiers in Medicine ·Luz María Medrano, Juan Berenguer, (unknown), Juan González‐García, Cristina Díez, Víctor Hontañón, Pilar García‐Broncano, Luis Ibáñez, José M. Bellón, María Ángeles Jiménez‐Sousa, Salvador Resino	12
11	HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients 2021 ·Frontiers in Immunology ·Oscar Brochado‐Kith, Isidoro Martínez, Juan Berenguer, Juan González‐García, (unknown), Daniel Sepúlveda‐Crespo, Cristina Díez, Víctor Hontañón, Luis Ibáñez, Leire Pérez‐Latorre, Amanda Fernández‐Rodríguez, María Ángeles Jiménez‐Sousa, Salvador Resino	17
12	Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014) 2019 ·Scientific Reports ·Sonia Vázquez‐Morón, Juan Berenguer, Juan González‐García, María Ángeles Jiménez‐Sousa, (unknown), (unknown), Manuel Crespo, Carmen Quereda, José Sanz, Ana Carrero, Víctor Hontañón, Ana Avellón, Salvador Resino	8
13	Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis 2018 ·PLoS ONE ·Lize Cuypers, Ana Belén Pérez, Natalia Chueca, Teresa Aldámiz‐Echevarría, Juan Carlos Alados, Ana Martínez-Sapiña, Dolores Merino, Juan A. Pineda, Francisco Téllez, Núria Espinosa, Javier Salmerón, Antonio Rivero‐Juárez, María Jesús Vivancos, Víctor Hontañón, Anne–Mieke Vandamme, Féderico García	11
14	Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status 2018 ·Cells ·Pilar García‐Broncano, Luz María Medrano, Juan Berenguer, Juan González‐García, María Ángeles Jiménez‐Sousa, Ana Carrero, Víctor Hontañón, Josep M. Guardiola, Manuel Crespo, Carmen Quereda, José Sanz, (unknown), Javier López Jiménez, Salvador Resino, (unknown)	12
15	Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study 2018 ·AIDS Patient Care and STDs ·(unknown), Helen Dolengevich-Segal, Ignacio Valero, Alfonso Cabello, María Jesús Téllez, José Sanz, Leire Pérez‐Latorre, José Ignacio Bernardino, Jesús Troya, Sara de la Fuente, Otilia Bisbal, Ignacio de los Santos, Sari Arponen, Víctor Hontañón, José L. Casado, Pablo Ryan, (unknown)	89
16	Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients 2018 ·AIDS ·Luz María Medrano, Pilar García‐Broncano, Juan Berenguer, Juan González‐García, María Ángeles Jiménez‐Sousa, Josep M. Guardiola, Manuel Crespo, Carmen Quereda, José Sanz, (unknown), Ana Carrero, Víctor Hontañón, María Ángeles Muñoz‐Fernández, Salvador Resino	29
17	Treatment of pulmonary and extrapulmonary tuberculosis 2018 ·Enfermedades infecciosas y microbiologia clinica (English ed ) ·(unknown), (unknown), Víctor Hontañón, (unknown)	9
18	Tratamiento de la enfermedad tuberculosa pulmonar y extrapulmonar 2017 ·Enfermedades Infecciosas y Microbiología Clínica ·(unknown), (unknown), Víctor Hontañón, (unknown)	10
19	Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study 2016 ·PLoS ONE ·Karin Neukam, Núria Espinosa, Antonio Collado, (unknown), (unknown), Antonio Rivero‐Juárez, Víctor Hontañón, (unknown), Josefa Ruiz‐Morales, Dolores Merino, Ana Carrero, Francisco Téllez, María Rios, José Hernández‐Quero, (unknown), Inés Pérez‐Camacho, (unknown), Juan Macı́as, Juan A. Pineda, (unknown)	6
20	Prognostic Value of Transient Elastography in Human Immunodeficiency Virus-Infected Patients With Chronic Hepatitis C 2016 ·Open Forum Infectious Diseases ·Leire Pérez‐Latorre, Antonio Rivero‐Juárez, Víctor Hontañón, Cristina Díez, (unknown), Luz Martı́n-Carbonero, Marisa Montes, José M. Bellón, Teresa Aldámiz‐Echevarría, Ana Carrero, Antonio Rivero, Juan González‐García, Juan Berenguer	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact